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Computed Tomography–Derived 3D
Modeling to Guide Sizing and Planning of
Transcatheter Mitral Valve Interventions
Joris F. Ooms, MD,a Dee Dee Wang, MD,b Ronak Rajani, MD,c Simon Redwood, MD,d Stephen H. Little, MD,e
Michael L. Chuang, MD,f Jeffrey J. Popma, MD, PHD,f Gry Dahle, MD,g Michael Pfeiffer, MD,h Brinder Kanda, MD,i
Magali Minet, MSC,j Alexander Hirsch, MD, PHD,a,k Ricardo P. Budde, MD, PHD,k Peter P. De Jaegere, MD, PHD,a
Bernard Prendergast, MD,c William O’Neill, MD,b Nicolas M. Van Mieghem, MD, PHDa

ABSTRACT
A plethora of catheter-based strategies have been developed to treat mitral valve disease. Evolving 3-dimensional (3D)
multidetector computed tomography (MDCT) technology can accurately reconstruct the mitral valve by means of
3-dimensional computational modeling (3DCM) to allow virtual implantation of catheter-based devices. 3D printing
complements computational modeling and offers implanting physician teams the opportunity to evaluate devices in
life-size replicas of patient-speciﬁc cardiac anatomy. MDCT-derived 3D computational and 3D-printed modeling provides
unprecedented insights to facilitate hands-on procedural planning, device training, and retrospective procedural evaluation. This overview summarizes current concepts and provides insight into the application of MDCT-derived 3DCM and
3D printing for the planning of transcatheter mitral valve replacement and closure of paravalvular leaks. Additionally,
future directions in the development of 3DCM will be discussed. (J Am Coll Cardiol Img 2021;-:-–-) © 2021 by the
American College of Cardiology Foundation.

P

re-procedural planning with 3-dimensional
(3D)

multidetector

computed

tomography

(MDCT) has proven to be a prerequisite plan-

A plethora of catheter-based strategies aim to tackle
mitral valve defects. Whereas the aortic root arguably
represents

a

relatively

straightforward

tubular

ning tool for successful transcatheter aortic valve

structure, the mitral valve features a more complex

replacement (TAVR) in elderly patients with degener-

conﬂuence of surrounding structures and introduces

ative tricuspid aortic valve stenosis (AS) who are at

patient-speciﬁc

elevated operative risk (1).

individualized

From the

a

particularities.
advanced

This

planning.

requires

Traditionally,
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ABBREVIATIONS

echocardiography has been the mainstay

acquisition, segmentation, and understanding of the

AND ACRONYMS

of imaging. However, there are limitations

proposed cardiac intervention using available cardiac

to using single-modality imaging for trans-

imaging applications (4,8).

catheter pre-procedural evaluation. Two-

MDCT ACQUISITION. A detailed overview of MDCT

dimensional

often

image acquisition is beyond the scope of this paper, but

unable to visualize the trajectory for intra-

in general, MDCT 3D modeling requires contrast-

cardiac devices in relation to surrounding

enhanced, electrocardiography-gated MDCT acquisi-

anatomic

transesophageal

tion without too stringent electrocardiographic dose

echocardiography (TEE) has limited spatial

modulation. Iodinated contrast is injected intrave-

resolution and may be hampered by dropout

nously at a rate of #4 ml/s. However, this may vary, as

artifacts that may mimic perforations or

protocols between scanners, hospitals, and patients

leaks (2). It is this spatial resolution that is

differ. The use of a saline/contrast ﬂush should be

essential in complex catheter-based mitral

determined based on indication. Image reconstruction

calciﬁcation

interventions, as it enables adequate device

should be performed for the entire cardiac cycle at 5%

MDCT = multidetector

sizing and detailed assessment of the valve

to 10% increments of the R-R interval resulting in 10 to

computed tomography

and its surroundings.

20 datasets per cardiac cycle. The reconstructed slice

3D = 3-dimensional
3DCM = 3-dimensional
computational modeling

3Dp = 3-dimensional printing
LA = left atrium/atrial
LV = left ventricle/ventricular
LVOT = left ventricular outﬂow
tract

LVOTO = left ventricular
outﬂow tract obstruction

MAC = mitral annular

echocardiography

structures.

3D

is

Improvements in MDCT spatial resolution,

thickness should be <1 mm. Depending on the intra-

THV = transcatheter heart

acquisition speed, and reconstruction algo-

cardiac region of interest and the procedure to be

valve

rithms enable the derivation of accurate

performed, speciﬁc phases in the cardiac cycle are

TMVR = transcatheter mitral

virtual 3D reconstructions of cardiac struc-

valve replacement

selected for segmentation. The mid to late diastolic

tures

catheter-based

phase is required for maximal mitral annulus di-

procedures. Compared with echocardiography and

mensions. Conversely, annular dimensions in the mid

cardiovascular magnetic resonance imaging (CMR),

to late systolic phase are required for minimal mitral

MDCT has superior spatial resolution and allows

annular dimensions (8).

PVL = paravalvular leakage

for

to

isotopical

virtually

imaging.

test

3-dimensional

printing

(3Dp), based upon MDCT-derived 3D computational
models, complements virtual modeling and offers the
opportunity to implant devices in life-sized casts of
the cardiac anatomy (3). The 3D-printed modeling
facilitates hands-on procedural planning, device
training, and retrospective procedural evaluation.
Ultimately, physicians may better understand a
patient’s unique anatomy and can bench test future
catheter-based interventions (4–6). A clear distinction
has to be made between 3D computational models
and simulation, the latter using tissue/device properties and their respective interactions to predict
structural/functional outcome. Furthermore, by adding computational ﬂuid dynamics to these models,
blood ﬂow is simulated (7).
Herein, we provide a comprehensive overview of
MDCT-derived 3D modeling in transcatheter mitral
valve procedures including computational (virtual)
modeling and printing. We place this technology in
the

perspective

of

transcatheter

mitral

valve

replacement (TMVR) and mitral paravalvular leakage
(PVL) closure

IMAGE SEGMENTATION. Image segmentation is a

process in which an anatomic label is assigned to a set
of pixels that share similar characteristics. Geometric
analysis and sizing become possible as different
anatomic structures emerge in the digital image.
MDCT is the only modality able to isotopically image
the heart, meaning that volume pixels (voxels) are
identical in size in the x, y, and z planes. Manual
segmentation of cardiac chambers, valves, and great
vessels is time-consuming and has high interobserver
variability. Specialized software packages offer (semi)
automated segmentation processes (9,10) (Figure 1). In
semiautomated segmentation, users label the cardiac
structures and indicate thresholds for the gray value
range in which those structures are optimally visualized. With this input, segmented 3D models of the
heart chambers and great vessels are automatically
obtained from MDCT images using either volume
rendering (VoR) or computational modeling (CM)
(Figure 2). In VoR, a grid of voxels is visualized using
transparency and coloring. In CM, voxels are used to
derive a mesh structure of a multitude of triangles (the
amount depends on the level of convexity and detail

BASIC PRINCIPLES OF MDCT-DERIVED 3D

requested). Although a VoR model allows rapid visu-

COMPUTATIONAL MODELING

alization of the grayscale in 3D, it has limited capabilities for downstream operations such as automated

The cornerstone of MDCT-derived 3D computational

quantiﬁcation. CM enables automated analysis of

modeling (3DCM) and 3Dp is based upon the

anatomic

following

insight, and can be converted to a 3D-printed model. A

individual

guidelines

for

MDCT-

structures,

provides

enhanced
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F I G U R E 1 Heart Segmentation

Semi-automated segmentation
Using specialized software

B
A

C
Processed MDCT Images

Whole heart 3D virtual model

(A) Processed multidetector computed tomography (MDCT) images are loaded into specialized segmenting software. (B) Using dedicated
software packages, essential cardiac structures such as the aorta (red) and left ventricle (pink) are marked after which the software semiautomatically identiﬁes the MDCT-rendered volumes of the aorta, left ventricle, left atrium, and pulmonary vessels (purple). From these data,
segmented 3-dimensional (3D) computational models of the heart chambers and great vessels are automatically obtained. (C) The whole
heart MDCT-derived 3D computational model can be printed or virtually assessed.

3D computational model can be converted to ﬁles with

asymmetrical patient anatomy with symmetrical de-

different extensions, serving different purposes. For

vice shape. Sizing an asymmetrical 3D oriﬁce can be

example, the model might be saved as a stereolitho-

challenging, and 2 methods are generally used.

graphic ﬁle (.STL), facilitating 3Dp, or as an object ﬁle

The conventional method uses MDCT images (axial

(.OBJ), enabling assessment in virtual reality. Most

thin sections) to obtain a plane at the level of basal

models in this paper are created using the CM method;

insertion of the mitral leaﬂets into the mitral annular

alternative techniques are highlighted where appli-

ring creating a hinge-point during the mid to late

cable. Once cardiac structures are virtually modeled, a

diastolic phase of the ventricular cycle. Subsequently,

broad spectrum of clinical applications becomes

using the double oblique view, the mitral annular

available, including assessment of ventricular and

dimensions are captured. This completely manual

atrial dimensions, characterizing heart defects, pro-

technique, which is de facto planimetry, relies

cedural planning, and the design and geometric vali-

heavily on operator experience to provide the accu-

dation of medical devices (10–13).

rate annular size and landing zone for a virtual

Various (semi)automated segmentation packages

transcatheter heart valve (THV) (10) (Figures 2A and

are available including but not limited to: Mimics

2B). This technique does not accurately reﬂect the 3D

Innovation

structure of the saddle-shaped mitral annulus. Its

Suite,

3D

Slicer,

Vitrea,

TeraRecon,

3Mensio, Solidworks, and Vascular Modeling Toolkit

height, in particular, is challenging to incorporate.

(4). In this paper, the Mimics software package

In an alternative VoR-based method, the analyst

(Materialise NV, Leuven Belgium) was used unless

tracks the mitral annulus using reference points in

stated otherwise.

multiple planes around a user-deﬁned center point
COMPUTATIONAL

(centrally located in the mitral oriﬁce), which creates a

Sizing an asymmetrical 3D oriﬁce. As

3D reconstruction of the mitral annulus (Figures 2C and

existing devices in structural heart disease are

2D). In a method based on 3DCM, mesh models of the

generally symmetrical and available in speciﬁc sizes,

left atrium (LA), left ventricle (LV), and calcium (if

the key to pre-operative assessment is to match

present) are used to position mitral annular reference

GENERAL
MODELING.

CONCEPTS

IN

3D
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F I G U R E 2 Methods to Derive the Virtual Annulus Using MDCT

A

C

E

B

D

F

(A) Conventional sizing method: Cross-sectional view of the left heart including the large left atrium, left ventricle, and aortic valve prosthesis. The orange line
represents the double oblique view visualized in B. (B) Axial thin section of the mitral annulus demonstrating severe mitral annular calciﬁcation. The red ellipse is
manually ﬁtted onto the annulus, allowing derivation of the maximal and minimal annular diameters. (C) Volume rendering method: a 3D annulus was created around a
user-deﬁned center point (yellow dot). (D) Atrial view, annular dimensions were: area derived Ø 26 mm, max. Ø 31 mm, min. Ø 20 mm. (C and D) Images were obtained
with the 3Mensio software package. (E) 3D computational modeling method: a MDCT-derived 3D computational model of the left ventricle (pink) and mitral annular
calciﬁcation (yellow) allows semiautomated mitral annulus tracing (white reference points and green line). (F) Using reference points, a 3D virtual mitral annulus is
computed and used to compute the best-ﬁt plane (orange lines) and associated annular dimensions (area derived Ø 23 mm, max. Ø 30 mm, min. Ø 16 mm). (E and F)
Images were obtained with the Mimics software package. All images originate from the same MDCT scan. Abbreviations as in Figure 1.

points (Figures 2E and 2F). From these references,

Virtual device implantation. MDCT-derived 3DCM al-

dedicated software constructs a smooth 3D virtual

lows ﬁtting of a geometric shape or a digitalized 3D

annulus derived from a series of Fourier approxima-

virtual device. An empirical starting point for device

tions for each of the spatial coordinates (x, y, z) (sem-

and size selection is the area-derived diameter of the

iautomated). The contour of the annulus is then

reconstructed annulus or oriﬁce. The selected device

projected onto its best-ﬁt plane, which is calculated

is automatically centered around the geometric

using the least squares method (14) (Figure 2D). This

midpoint of the best-ﬁt plane. Given the asymmet-

projected annulus is used to derive the annular area

rical shape of anatomic structures, it is essential to

and diameters. Consequently, the best-ﬁt plane serves

visually assess ﬁtting of the device in multiple angles.

as the landing zone for the virtual THV implant.

Spatial interaction with surrounding structures can

Compared with the conventional method in general,

also be tested, thereby identifying possible malap-

both the VoR and the 3D computational method allow

position or obstruction (9) (Figure 3). This concept of

for a 3D reconstruction of the mitral annulus. 3DCM

an adequate visual ﬁt is essential in MDCT-derived

further provides a full mesh model of the surrounding

3DCM, but lacks any appreciation of tissue and de-

structures allowing detailed assessment of asymmet-

vice characteristics to interpret device-host in-

rical structures in a sole model. Furthermore, it en-

teractions. Specialized models that incorporate tissue

ables semiautomated measurement of asymmetrical

and device properties in virtual models are under

structures, volumes, and oriﬁces reducing variability

development and have reasonable accuracy in TAVR

and potentially lessening processing time.

simulation of implants and prediction of residual
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F I G U R E 3 MDCT-Derived 3D Computational Model of the Left Heart With Severely Calciﬁed Mitral Annulus

A

B

C
Aorta

LA

Aorta
Virtual Annulus

Aorta

THV

LV
LV

LV

(A) MDCT-derived 3D computational modeled reconstructions of the left atrium (LA) and pulmonary veins (purple), mitral annular calciﬁcation (MAC) (yellow), left
ventricle (LV), and aorta (red). The mitral annulus is traced with green dots. MAC is used as a reference point for virtual annular construction (green line). (B) Surgical
view of the same calciﬁed mitral annulus. (C) Virtual implantation of a cylinder representing a 23-mm Sapien3 transcatheter heart valve (THV) (Edwards Lifesciences,
Irvine, California). Abbreviations as in Figure 1.

paravalvular leaks, conduction disorders, and cal-

creation of model parts (7%), and CMR (3%) (4). MDCT

cium displacement (7,15).

offers excellent spatial resolution, allowing clear
depiction of pathological calcium and does not

3D PRINTING

generally require image quality adjustment before
anatomic segmentation (17). The TEE-derived 3Dp is

MDCT-derived 3D computational models incorporate

limited by suboptimal detection of the subvalvular

spatial relationships on a 2-dimensional screen and

apparatus, left ventricular geometry, tissue differen-

might impair complete understanding of the detailed

tiation, or calcium deposits. Additionally, because

3D reality. Consequently, a full understanding of the

spatial resolution of ultrasound is best along the

model requires meticulous and time-consuming

longitudinal plane, views from different angles need

assessment from multiple angles. However, trans-

to be fused to capture 2 perpendicularly aligned

formation of these computational (virtual) models

structures and master resolution issues. Resolution is

into physical form by means of 3Dp can resolve these

also limited by the probe-speciﬁc properties of the

limitations. The availability of a patient-speciﬁc

piezoelectric crystal. Ultimately, TEE does not allow

physical model can facilitate medical teaching,

for isotropic imaging and is therefore less suitable for

exploration of valve function, and pre-procedural

3Dp. CMR avoids radiation exposure and has excel-

planning (11). In congenital heart disease, 3Dp has

lent tissue characterization abilities, but is hampered

been shown to be helpful in pre-procedural planning

by inferior spatial resolution that may impair detec-

of surgical correction (16). Subsequently, this tech-

tion of small intracardiac defects. However, it has

nique has been gradually adopted to help plan

been successfully applied to 3D-printed modeling in

different catheter-based interventions for structural

congenital heart disease (8).

heart disease (4). In the mitral space, 3Dp models

3D-printed models in cardiovascular disease are

have been instrumental in the identiﬁcation of de-

typically composed of a variety of rigid and/or ﬂexible

fects,

materials (4,18,19). Rigid material, such as poly-

device

sizing,

and

procedure

execution

(Figure 4) (11,17)

butylene terephthalate, acrylonitrile-butadiene sty-

A recent systematic review on 3Dp in adult heart

rene, and polyamide, are suited for mimicking

valve disease identiﬁed MDCT as the ﬁrst choice

prostheses and calcium. They can also be used if the

modality for 3Dp (62%), followed by ultrasound

goal of the print is to acquire complementary

(28%), computer aided design with separate manual

anatomic insight (educational purposes), regardless
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F I G U R E 4 Pre-Procedural Assessment Using 3D-Printed Models of the Mitral Valve

A

B
neo

-LV
OT

Anterior

Aorta
Mitral bioprosthesis

THV

Fo
s

sa

ov
ali

s

Left
atrium
Occluder devices
Posterior

(A) MDCT-derived, 3D-printed model of the left heart with a 26-mm Sapien3 prosthesis implanted in the mitral annulus allowing for detailed
evaluation of the expected neo-left ventricular outﬂow tract from a left ventricular viewpoint. (B) Surgeon’s view of the left atrium of a 3Dprinted model in which occluder devices are positioned along the frame of a bioprosthetic mitral valve. THV ¼ transcatheter heart valve; other
abbreviations as in Figure 1.

of any appreciation of tissue characteristics. Flexible

techniques for mitral repair and replacement presents

materials, including, but not limited to, thermoplastic

new treatments for a signiﬁcant number of patients

elastomers (i.e., Tango Plus, Agilus, HeartprintFlex)

who would otherwise be denied conventional surgery

and printable silicones, are increasingly developed to

(21). TMVR is beset by complex anatomic challenges,

mimic human tissue and are more suitable for ﬁtting

including its central cardiac location; elliptical,

actual devices. Other materials, such as resins, can be

saddle-shaped

used to yield either solid or ﬂexible models depend-

apparatus. Additionally, it introduces the risk of left

annulus;

and

associated

chordal

ing on the printing technique used. By combining

ventricular outﬂow tract (LVOT) obstruction (22,23)

materials of different rigidity in 1 3D-printed model,

and valvular foreshortening in the LA. TMVR can be

valve calciﬁcation or the presence of a prosthetic

performed in previously surgically implanted annular

valve can be replicated.

rings, bioprostheses, and the native annulus (24–26).

In practice, both healthy and diseased native valve

A failing bioprosthesis, mitral ring, or excessive

tissue is highly heterogeneous with variable physical

mitral annular calciﬁcation may provide anchoring

properties (20). Currently available 3Dp material does

opportunities for THV designs that were originally

only slightly approach the properties of arterial tis-

developed for aortic valve implantation (24,27). In the

sue, and is still far away from reliably representing

native noncalciﬁed mitral annulus, the implanted

the human heart (17). The mechanical properties of

valve uses other anchor opportunities and typically

the ideal printed model would resemble tissue-

dominates its direct surroundings, which has conse-

speciﬁc

quences for the risks of PVL and left ventricular

characteristics

under

different

circum-

stances. In reality, however, a trade-off between

outﬂow tract obstruction (LVOTO). To address this,

practicality and cost determines the ﬁnal 3D print. As

multiple dedicated designs for TMVR are under

such, 3Dp of the heart is still in its infancy and under

development or have entered clinical trials (25,28).

further development.

MDCT-derived 3DCM may prove particularly helpful

CLINICAL APPLICATIONS OF 3D COMPUTATIONAL
MODELING: TRANSCATHETER MITRAL
VALVE REPLACEMENT

for TMVR, as various TMVR sizes and designs can be
evaluated in virtual implants, generating information
to enhance procedural efﬁcacy and patient safety.
VIRTUAL ANNULUS CREATION AND VALVE SIZING.

Mitral regurgitation and mitral stenosis are the sec-

A surgical prosthesis is traceable on MDCT planim-

ond and third most frequent clinically relevant valve

etry. Additionally, implanted prosthesis type and size

diseases

can be deducted from these images, leading to a

(21).

The

advent

of

catheter-based
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relatively straightforward THV sizing and provision of

an increase in LVOT gradient of $10 mm Hg compared

a ready-made best-ﬁt plane (29). However, blooming

with baseline (36). In previous studies, which used

artifacts may affect measurements (30). Sizing the

MDCT for prediction of the minimal neo-LVOT area, 2

native mitral annulus (with/without annular calcium)

methods of neo-LVOT estimation were described. In 2

proves more challenging as its borders are asymmet-

reports, manual planimetry was performed on cross-

rical and less pronounced. In such cases, planimetry

sectional images with a THV projected on the mitral

may omit important information. Additionally, the

annulus in the mid to late systolic phase, when the

native annulus varies in size during the cardiac cycle,

neo-LVOT area is smallest (22,35). Using this method,

which warrants careful selection of cardiac phase

the suggested cut-off value for the neo-LVOT area

when creating and measuring the virtual annulus. Its

with

complex shape and close relation with the ventricle

was #170.0 mm 2 (22).

greatest

discriminatory

value

for

LVOTO

ideally require virtual 3D reconstruction as described

The other method uses an MDCT-derived 3D

in the section “General concepts in 3D computational

computational model of the left heart with a virtual

modeling.”

THV implant that allows semiautomated calculation

In the native mitral annulus, the trigone-to-trigone

of the minimal neo-LVOT area through volumetric

connection represents an additional landmark in this

assessment. With the neo-LVOT identiﬁed, its 3D

process (31). If necessary, subtle adjustments in the

relation to the implanted THV, LV, and original LVOT

virtual mitral annulus shape can be made. The original

becomes clear. Repeated ﬁtting using various virtual

annular anatomy may be severely distorted by mitral

implants and manipulating device type, size, cardiac

annular calciﬁcation (MAC), allowing limited use of

phase, implant depth, and co-axiality within the

common structural landmarks (9). However, calciﬁca-

mitral annular plane is possible (Figure 5). Because

tion can be used as a landmark for annular sizing. In

volumetric data concerning the LV and THV can be

MDCT-derived 3DCM, calcium is segmented as a

derived from the computational model, obstruction

separate structure and integrated in the structural

can be expressed as a fraction of the original LVOT.

model, thereby facilitating virtual reconstruction of

Other predictors for LVOTO in TMVR, such as the

the mitral annulus (Figures 2E, 2F, and 3). Still, caution

angle between the native LVOT and aorta, AML

must be taken with annulus reconstruction based on

length, and septal wall thickness, may be evaluated in

MAC, as calcium may cause blooming artifacts and

these models, allowing review of complex 3D struc-

potentially affect adequate prosthesis sizing (32).

tures in different hypothetical situations (22,37).

The virtually reconstructed mitral annulus facili-

Furthermore, strategies can be planned to tackle

tates automated calculation of the reference plane

projected

(best-ﬁt plane, “General concepts in 3D computa-

balloon inﬂation, LVOT post-dilatation, or alcohol

tional modeling” section) on which a virtual pros-

septal ablation). As such, the model serves as a

thetic valve can be projected. Selecting multiple valve

patient-speciﬁc, virtual training ground allowing se-

sizes/types, and shifting their position within the

rial testing prior to the planned high-risk procedure

reconstructed annulus, helps to obtain an adequate

without clinical consequences. A study using this

visual ﬁt (Figure 3C). However, as this is a virtual

method found a cut-off value for the MDCT-derived

model without incorporation of tissue and device

neo-LVOT area of #189.4 mm 2 to have the greatest

characteristics, in vivo malapposition still poses an

discriminatory value for post-TMVR LVOTO (9).

important risk, especially in MAC (33).

result of strut protrusion and anterior mitral leaﬂet
(AML) displacement (34). This leads to the formation
of a new elongation of the native LVOT, which is
referred to as the neo-LVOT (35). Acquired LVOTO
neo-LVOT)

is

associated

(e.g.,

simultaneous

LVOT

Direct comparisons of the clinical accuracy of

NEO-LVOT. TMVR may cause LVOT deformation as a

(narrow/blocked

obstruction

with

procedure-related death, conversion to surgery, or
emergency percutaneous reintervention (22). MDCTderived 3DCM can estimate the neo-LVOT using

neo-LVOT prediction in pre- and post-TMVR MDCT
datasets

using

3D

computational

models

have

demonstrated excellent correlation with high reproducibility and accuracy (9). Comparing predicted and
post-TMVR neo-LVOT by manual planimetry of MDCT
images has also shown reproducibility with low
intraobserver and interobserver variability (22). Of
note, performance of neo-LVOT prediction with
MDCT planimetry and semiautomated MDCT-derived
3DCM have yet to be compared.

various valves with different implantation heights,
guiding TMVR (35).

MULTIPHASE

PLANNING

IN

LVOT

ASSESSMENT.

According to the latest Mitral Valve Academic

As experience with LVOTO in TMVR expands, it be-

Research Consortium criteria, LVOTO is classiﬁed as

comes evident that pre-procedural planning based on
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F I G U R E 5 Virtually Implanted Prosthetic Heart Valves With Calculated Neo-LVOT

Atrium 40% : Ventricle 60%

A

THV
*

LV

neo-LVOT

LV

Atrium 55% : Ventricle 45%

B
THV

*

LV

neo-LVOT
LV

(A, right) MDCT-derived 3D computational model of the left ventricle (LV) with severely calciﬁed mitral annulus (yellow) in a medio-lateral
view. (Left) The same model viewed from the aorta. A virtual cylinder representing a 23-mm Sapien3 transcatheter heart valve (THV) was
implanted at a 40/60 position. The neo left ventricular outﬂow tract (neo-LVOT) (blue circle, left; blue asterisk, right) is automatically
calculated and has an area of 138 mm2 (58% native LVOT occupancy). (B) The same LV model as in A with THV implanted at a 55/45 position.
The calculated neo-LVOT area is 162 mm2 (39% native LVOT occupancy). Abbreviations as in Figure 1.

a single cardiac phase might be too crude. As LVOT

when there was no predicted early systolic obstruc-

dimensions are smallest in the end-systole, around

tion (38). These ﬁndings underpin the relevance of a

40% of the R-R interval, any geometric LVOTO after

multiphase approach when evaluating TMVR eligi-

TMVR would ﬁrst occur in that phase. However, the

bility. The creation of full-cycle MDCT-derived 3D

vast majority of the stroke volume is ejected in the

computational models, or 4D computational models,

early and mid-systolic phase, implying that a func-

will add to effective patient/device selection in

tional, clinically relevant LVOTO should occur at that

TMVR.

time. A report on pre-procedural multiphase neo-

EVALUATING

LVOT assessment in screening for TMVR using a

Transvenous transseptal TMVR is less invasive than

dedicated THV showed that patients with predicted

the transapical approach and rapidly becoming the

end-systolic obstruction performed well after TMVR

access strategy of ﬁrst choice (25). Superior and

THE

TRANSSEPTAL

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by
Elsevier on April 15, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.

APPROACH.

JACC: CARDIOVASCULAR IMAGING, VOL.

-, NO. -, 2021

Ooms et al.

- 2021:-–-

Pre-Procedural CT-Derived 3D Modeling of Mitral Interventions

posterior puncture through the interatrial septum

From this 3D annulus, a best-ﬁt annular plane is

facilitates catheter manipulation in the LA for device

computed using the least-squares method. This plane

orientation and positioning within the mitral appa-

can be used to derive the geometric centroid of the

ratus. MDCT can provide a roadmap and help deter-

mitral annulus (Supplemental Figure 2A). The ideal

mine optimal C-arm angles that may be fused with

anchoring point is obtained by drawing a line

live ﬂuoroscopic imaging (39). MDCT-derived 3D

perpendicular to the annular plane down to the

computational models enhance appreciation of the

epicardium of the LV. The suggested anchoring point

anatomic relations among the inferior vena cava,

for the tether is referred to as the orthogonal LV ac-

interatrial septum, and mitral annulus. Additionally,

cess point (Supplemental Figures 2B to 2D) (43). Once

by printing a 3D model of the right atrium, LA, and

the anchoring site is determined, the device can be

mitral annulus, the operator can undertake hands-on

virtually implanted and assessed for adequate ﬁt and

assessment of the transseptal puncture site. The

relation to the LVOT. 3D modeling provides an over-

optimal puncture site can be pre-determined fol-

view of complex interlinked structures that deter-

lowed by evaluation of the consequences for catheter

mine suitability for a dedicated THV.

manipulation when approaching the mitral valve.
Furthermore, catheters can be tested in terms of
ﬂexibility, crossability, and deliverability toward the
region of interest.
OPTIMAL FLUOROSCOPIC PROJECTIONS. Efforts have

been made to determine MDCT-derived optimal
ﬂuoroscopic projections for TMVR (40). However,

CLINICAL APPLICATIONS OF 3D
COMPUTATIONAL MODELING: MITRAL
PARAVALVULAR LEAKAGE CLOSURE
Signiﬁcant prosthetic PVL after surgical mitral valve
replacement is relatively common and reported in up
to 17% of patients at 15 years of follow-up (44). Risk

adequate visualization of the mitral annulus some-

factors include annular calciﬁcation, infection, suture

times requires impractical angles in the catheter lab-

technique, tissue integrity, and myocardial contrac-

oratory setting. Furthermore, optimal projections are

tion (45).

device-speciﬁc and vary greatly between subjects.
MDCT-derived 3DCM helps to compromise and

Echocardiography is the ﬁrst step to reveal PVL
location and quantiﬁcation (46). Accurate oriﬁce

determine the best workable ﬂuoroscopic views for

sizing is difﬁcult as a result of dropout artifacts and

the respective TMVR-related manipulations (Supple-

may lead to underestimation of severity. Pre-

mental Figure 1). Determining optimal projections

procedural MDCT assessment helps deﬁne PVL

prior to procedure commencement potentially re-

characteristics, strategy planning, and device/size

duces ﬂuoroscopy time and therefore radiation
exposure as well as contrast dosage (41).
PLANNING

WITH

DEDICATED

DEVICES. Numerous

selection. All MDCT imaging is associated with
blooming and device-related artifacts that may
impede accurate evaluation of valve integrity or leak

dedicated devices that have proprietary anchoring

sizing

mechanisms with unique spatial orientations in the

segmented to create a 3D model, it has the potential

LA, LV, and LVOT are being developed for TMVR (25).

to partially bypass excessive artifacts (at the cost of

(12,47).

However,

when

MDCT

data

is

Planning TMVR with MDCT-derived 3D computa-

variability). MDCT-derived 3DCM and virtual trans-

tional models may add substantially to determining

catheter closure device may improve accuracy and

the appropriate device for an individual patient.

offer complementary insights into interstructural re-

For example, the Tendyne device (Abbott, Abbott

lations and sizing.

Park, Illinois) utilizes an apical tethering mechanism

Determination of the cardiac phase is essential for

for device stabilization (28) (Supplemental Figure 2).

PVL analysis and is in systole for mitral PVL. Finding

The anchoring zone of the tether is in a coaxial posi-

the optimal phase is reﬁned by additional TEE infor-

tion with the LV apex. Deviations from that position

mation (48). To obtain a 3D computational model

could lead to loss of or excessive traction on the

from MDCT images, manual segmentation of the

valve, resulting in suboptimal placement or disloca-

cardiac walls is required based on subtle differences

tion of the valve. Identifying the optimal anchoring

in pixel gray value of the raw dataset. This is per-

zone relies on 3D MDCT imaging with subsequent

formed in the double oblique setting. From this seg-

conﬁrmation by procedural TEE and manual exami-

mentation, a 3D computational model is created.

nation (42). In MDCT, the mitral annulus is manually

After manual adjustment, a patient-tailored model is

traced using both short- and long-axis views leading

created in which prosthesis shadowing and blooming

to the formation of a virtual segmented annulus.

artifacts are reduced to reveal essential details for
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F I G U R E 6 Pre-Procedural Assessment of Mitral Prosthetic Paravalvular Leak

A

B

D

C

E

F

H

G

Images are obtained from a patient with a St. Jude 27-mm mechanical mitral prosthesis. (A) Transesophageal echocardiography (TEE) image in the 2-chamber view
showing the mitral valve with no obvious paravalvular defect. (B) The same 2-chamber image with color-Doppler demonstrating a signiﬁcant paravalvular leakage
(PVL) on the postero-medial side of the prosthesis. (C) 3D-TEE image with color Doppler showing a PVL (green arrow). (D) Pre-procedural, MDCT-derived 3D
computational model of the prosthetic mitral valve from a surgical view in early diastole, the paravalvular defect is apparent on the postero-medial side. (E) Surgical
view of the 3D reconstructed mitral prosthesis—the paravalvular defect measures 9.7  4.0 mm. (F) Based on measurements derived from the model in D and E, a
10  5 mm Amplatzer cardiac plug (Abbott, Abbott Park, Illinois) (red arrow) was selected. (G) Post-implantation TEE with the plug in situ (red arrow) showing
reduced PVL. (H) 3D-TEE with color Doppler of the occluded PVL with the plug visible (red arrow). Abbreviations as in Figure 1.

complex lesion sizing. Additionally, MDCT-derived

appearances is essential. To further clarify anatomic

3DCM provides information on PVL location in rela-

relations, the virtual model can be printed allowing

tion to the inter-atrial septum and determination of

bench testing (Figure 4B).

an optimal catheter trajectory. Indeed, such modeling

Figures 6A to 6C provide TEE illustration of PVL

can determine whether percutaneous PVL closure is

affecting

feasible at all (49). However, detailed knowledge

Because the dimensions of the leak could not be

about

adequately

normal

appearances

as

well

as

suture

a

mechanical
appreciated

prosthetic
on

mitral

these
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C ENTR AL I LL U STRA T I O N Pre-Procedural Planning of Mitral Valve Interventions Using
MDCT-Derived 3-Dimensional Virtual and Printed Models
Modeling transcatheter mitral valve replacement

MDCT-derived 3D computational
model of the left heart

3D annulus
evaluation

Virtual valve
sizing

3D-printed model with
1:1 valve implantation

Modeling paravalvular leakage
Localization of leakage

Evaluation of dimensions and
accessiblity

Modeling of the neo-left ventricular outflow tract
Positioning of virtual
transcatheter
heart valve

Neo-left ventricular
outflow tract
quantification

Evaluation of neo-left
ventricular outflow
tract in 3D-Printed models

Ooms, J.F. et al. J Am Coll Cardiol Img. 2021;-(-):-–-.

MDCT-derived, 3-dimensional (3D), computational modeling and physical printing generate anatomic insights to help test, plan, and execute
transcatheter mitral valve replacement and paravalvular leakage closure. MDCT ¼ multidetector computed tomography.

complementary

computational

contrast. Additionally, it exposes patients to neph-

model was obtained, allowing measurements from

MDCT-derived

3D

rotoxic contrast and could evoke allergic contrast

different angles to enable appropriate sizing and

reactions. In patients with renal dysfunction, pro-

closure device selection. Procedural results are

phylactic ﬂuid administration prior to scan acquisi-

depicted in Figures 6D to 6H.

tion might induce variability in loading conditions.

In our experience, compared with TEE, MDCT-

MDCT-derived modeling requires image acquisition

derived 3DCM provides superior information con-

throughout the entire cardiac cycle, and thus comes

cerning location, sizing, and structural interactions of

with additional ionizing radiation dose exposure.

the lesion at hand when planning transcatheter PVL
closure.

MDCT-DERIVED 3D COMPUTATIONAL AND PRINTED
MODELS. An MDCT-derived 3D computational model

LIMITATIONS OF MDCT-DERIVED

represents a static model and therefore only approx-

PRE-PROCEDURAL MODELING

imates real-time cardiac dynamics. Each segmented
model is derived from 1 cardiac phase, which stresses

MDCT ACQUISITION. MDCT has its inherent limita-

the importance of adequate phase selection (i.e., ex-

tions. Its acquisition can be limited by arrhythmias or

pected

low cardiac output resulting in reduced luminal

Currently, MDCT-derived 3D models do not allow for

dimensions

being

minimal/maximal).
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shifting between phases once segmentation has been

element analysis to allow modeling of the whole

performed. Consequently, acquiring a model of the

(complex) structure (20,54,55). In TMVR, several

whole cardiac cycle requires laborious separate model

cases are described in which a ﬁnite element model

segmentation and construction of each phase. Auto-

was used to predict outcome and aid pre-procedural

mation in segmentation could solve these issues. 3Dp

planning. By incorporation of mechanical properties

relies on a single cardiac phase, making it less suit-

of the annulus, its calcium, the leaﬂets, and the

able for the evaluation of dynamic obstruction.

selected THV, a simulation could be run predicting

Furthermore, important hemodynamic concepts and
procedural

hemodynamic

ﬁlling

status

are

not

considered in a static model and may result in inac-

valve-ﬁt and potential LVOTO (15,55,56). The current
experience is proof of concept. Larger-scale validation studies are needed.

curate sizing in vivo. The lack of incorporation of
speciﬁc device and tissue properties in current

COMPUTATIONAL FLOW DYNAMICS AND FLUID-

MDCT-derived geometric models poses a problem

STRUCTURE INTERACTION MODELING. Incorpora-

when devices are implanted in real life. Although

tion of computational ﬂuid dynamics (CFD) into

virtual device implantation may suggest a proper ﬁt,

MDCT-derived 3D computational models allows

in vivo implantation may cause marked tissue shift or

the assessment and quantiﬁcation of PVL. These

altered device conﬁguration leading to malapposition

models can also be used to evaluate the effect of

or rotation. Moreover, the absence of standardized

valve size, type, and depth of implantation on

protocols for device sizing in virtual 3D models could

hemodynamics

lead to interobserver variability. 3D-printed models

functional LVOTO. It should be acknowledged that

are increasingly acquired to assist in pre-procedural

the CFD models are based on a number of as-

planning

sumptions such as pressure gradients, viscosity,

of

transcatheter

structural

heart

in-

terventions. However, cautious interpretation of
their signiﬁcance is necessary because these models

and

therefore,

the

degree

of

and ﬂow characteristics. Laminar and/or turbulent
ﬂow patterns are incorporated (55).

still are a relatively raw representation of reality.

In addition to the above, analysis of the Fluid

Additionally, they lack standardized, reproducible

Structure Interaction (FSI) can conceptually be used

methods for measuring distances/areas. However,

for the assessment of the effects of the interaction

efforts for structured veriﬁcation have been made

between a ﬂuid and adjacent structures (i.e., blood

(50).

vs. valve/cardiac tissue). Resulting in the analysis of

FUTURE DIRECTIONS

the subsequent effects on cardiac structures (53,57).

the changes in ﬂow and ﬂow patterns, pressures, and
For instance, it might facilitate prediction of the ef-

Several developments could further enhance MDCT-

fect of dimensional changes in LVOT after TMVR,

derived 3D modeling and will contribute to a future

inducing a systolic anterior motion of the AML

of patient-tailored valve replacement.

through pressure differences (Venturi effect) that in

INCORPORATION OF TISSUE AND DEVICE PROPERTIES

turn affect neo LVOT ﬂow. In addition of the predic-

IN COMPUTATIONAL MODELING. In vivo implanted

tion of hemodynamics, FSI may be of particular value

devices will affect the geometry/conﬁguration of

of the assessment of valve durability as (unwanted)

surrounding tissue and vice versa (51). Incorporation

ﬂow patterns may induce endothelial cell changes

of tissue/device mechanical properties and their ge-

(58). Although progress has been made in creating FSI

ometry and dimensions in a computational model

models of individual components associated with

predicts

these

geometric/conﬁgurational

changes

mitral valve replacement (53,57), full TMVR models

and, thereby, assists in the selection of the optimal

are experimental, are scarce, and cover only part of

device type and size (7,52). Patient-speciﬁc geometry

the interactions (55).

is obtained from actual patient data (MDCT, CMR, 3D

A TMVR model fully incorporating tissue and de-

echo) and used to create a static model. Mechanical

vice properties; ﬂow dynamics; ﬂuid-structure inter-

properties are derived from ex vivo stress-strain an-

action models; and coupling of LV, LA, and aorta may

alyses. These experiments assess the changes in

further

conﬁguration/dimension of a structure upon expo-

structural heart interventions and will lead to an ul-

improve

hemodynamic

prediction

after

sure of stress. The changes in conﬁguration depend

timate form of patient-tailored medicine, in which a

on the amount and direction of the stress, the

valve is selected (or created) based on individual

composition, and the reference state of the material

simulations (54,59). However, given the complex

(7,53). Computer modeling and simulation use ﬁnite

nature of these models and the computational power
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required to create them, there is still a long road
ahead for clinical adoption.
BIOPRINTING. Most 3Dp materials aim to mimic

cardiac tissues. However, using actual (vivo) cardiovascular tissue might provide a solution for the crude
biomechanical representation of the human heart in
3Dp. 3Dp using vivo tissue is referred to as bioprinting
and the material used for printing is called bioink.
This

material

comprises

a

viscoelastic

medium

(mostly hydrogels) together with cells. Depending on
the cardiac structure required, bioink is often printed
on a scaffold (3D geometric structure), which can be
either biological or synthetic and could be modelled

HIGHLIGHTS
 Catheter-based interventions for complex defects of the mitral valve apparatus
are evolving.
 MDCT-derived 3D computational
modeling and 3D printing enhance risk
evaluation and planning of complex
transcatheter procedures.
 Incorporation of multiple cardiac phases,
tissue/device properties, and hemodynamics should optimize 3D modeling.

according to a patient’s anatomy (60). Although the
recreation of a fully functioning, patient-speciﬁc,

CONCLUSIONS

biological 3D print of the heart is somewhat futuristic at this point, progress has been made on separate

MDCT-derived 3DCM, and physical printing generate

parts (61,62). Future incorporation of tissue into the

unprecedented anatomic insights to help test, plan,

patient-speciﬁc anatomy could greatly enhance the

and execute complex transcatheter mitral valve in-

performance and authenticity of physical 3D-printed

terventions (Central Illustration). Further research is

models in valvular heart disease leading to increased

needed to establish these advanced techniques in

reliability in pre-procedural bench testing.

clinical practice.

VIRTUAL REALITY AND HOLOGRAPHIC PROJECTION.
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